The largest database of trusted experimental protocols

6 protocols using teicoplanin

1

Antimicrobial Susceptibility of Enterococci

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antimicrobial susceptibilities of 175 E. faecalis and 67 E. faecium strains were examined by using the disk agar diffusion (DAD) method in accordance with the Clinical and Laboratory Standards Institute (CLSI) guidelines.17 18 Erythromycin (15 µg), Tetracycline (30 µg), Ciprofloxacin (5 µg), Vancomycin (30 µg), Teicoplanin (30 µg), Norfloxacin (10 µg), Nitrofurantoin (300 µg), Quinopristin-Dalfopristin [Synercid (15 µg)] (Mast Co., UK), Chloramphenicol (30 µg), Gentamicin (10 µg), Linezolid (30 µg), and Ampicillin (10 µg) (HiMedia Mumbai Co., India) were used for antimicrobial susceptibility testing (AST).
In addition, minimum inhibitory concentrations (MIC) of the glycopeptide antibiotics i.e. Vancomycin and Teicoplanin (Sigma-Aldrich, Poole, Co., UK) against the E. faecalis and E. faecium isolates were determined using the microdilution broth method.17 18
E. faecalis ATCC 29212 (Vancomycin sensitive), E. faecalis ATCC 51299 (vanB positive), E. faecalis E206 (vanA positive) were used as quality control.
+ Open protocol
+ Expand
2

Methicillin Resistance Screening in S. aureus

Check if the same lab product or an alternative is used in the 5 most similar protocols
The disk diffusion method using cefoxitin (30 μg) disk in Mueller-Hinton agar (Merck, Germany) according to the CLSI was applied for the screening of methicillin resistance isolates. In addition, PCR assay was used for the detection of mecA gene.12
The Kirby–Bauer disk diffusion method was used to determine the susceptibility of the isolates against penicillin, ceftriaxone, amikacin, gentamicin, tobramycin, kanamycin, tetracycline, linezolid, teicoplanin, ciprofloxacin, rifampicin, quinupristin-dalfopristin, and trimethoprim-sulfamethoxazole (Mast Co., UK) based on the CLSI recommendation (CLSI 2019). The minimum inhibitory concentration (MIC) value for vancomycin, mupirocin, tigecycline, and fusidic acid was determined using the broth microdilution method. Results for fusidic acid and tigecycline were interpreted according to the European Committee for antimicrobial susceptibility testing (EUCAST) breakpoints (http://www.eucast.org). Low-level and high-level mupirocin resistance (LLMUPR, HLMUPR) were defined if MIC values of 8–256 µg/mL and ≥512 µg/mL were obtained. S. aureus strains ATCC 25923, ATCC 43300 and ATCC 29213 were used as reference strains.
+ Open protocol
+ Expand
3

Evaluating Antibiotic Resistance Patterns of MRSA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibiotic resistance pattern of isolates was evaluated using the Kirby Bauer method according to the CLSI instructions against amikacin (AMK), clindamycin (CLI), ciprofloxacin (CIP), erythromycin (ERY), gentamicin (GEN), kanamycin (KAN), linezolid (LIN), penicillin (PEN), quinupristin-dalfopristin (SYN), rifampicin (RIF), tobramycin (TOB), tetracycline (TET), teicoplanin (TEC), and trimethoprim-sulfamethoxazole (SXT) (Mast Co., UK). MRSA strains were identified phenotypically using the Cefoxitin disk diffusion method (30 μg) according to the CLSI guidelines and detection of the mecA gene as previously described [4 (link)].
The microdilution was performed to determine minimum inhibitory concentration (MIC) titer for antibiotics vancomycin (VAN), tigecycline (TIG), and fusidic acid (FUS) according to the procedure detailed in our previous report [4 (link)]. Results for fusidic acid and tigecycline were interpreted based on the European Committee for antimicrobial susceptibility testing (EUCAST) recommendations (http://www.eucast.org). The inducible and constitutive macrolide-lincosamide-streptogramin group B (iMLSB and cMLSB) resistance phenotypes were identified by erythromycin and clindamycin disks by the CLSI guideline (CLSI 2019). S. aureus ATCC 25923, ATCC 43300, and ATCC 29213 strains were used for antibiotic susceptibility testing quality control.
+ Open protocol
+ Expand
4

Comprehensive Antibiotic Susceptibility Testing

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Kirby–Bauer disc-diffusion method on Mueller–Hinton agar was used to test the susceptibility of the isolates against amikacin, gentamicin, tobramycin, kanamycin, tetracycline, erythromycin, clindamycin, linezolid, teicoplanin, ciprofloxacin, rifampicin, quinupristin-dalfopristin and trimethoprim-sulfamethoxazole (Mast Co., Bootle, UK) based on the CLSI guideline. Susceptibility to vancomycin, mupirocin, tigecycline and fusidic acid was assessed by the broth microdilution method to determine the MIC titre. The European Committee for Antimicrobial Susceptibility Testing (EUCAST) breakpoints was used to determine MIC titres of fusidic acid and tigecycline (EUCAST 2018). The results of other antibiotics were interpreted by using the CLSI 2018 breakpoints. Low-level and high-level mupirocin resistance (LLMUPR, HLMUPR), inducible macrolide-lincosamide-streptogramin group B (iMLSB) and constitutive (cMLSB) macrolide-lincosamide-streptogramin group B were identified based on the CLSI guideline. Susceptibility testing was quality controlled using S. aureus ATCC 25923, ATCC 43300 and ATCC 29213 strains. Powders of antibiotics were all obtained from Sigma Chemical Co. (St Louis, MO, USA).
+ Open protocol
+ Expand
5

Antibiotic Susceptibility Profiling of Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
The disk diffusion test was employed to determine the susceptibility of the isolates to vancomycin (30 µg), teicoplanin (30 µg), gentamicin (120 µg), linezolid (30 µg), ciprofloxacin (5 µg), erythromycin (15 µg), ampicillin (10 µg), tetracycline (30 µg) and rifampicin (5 µg) (Mast Group Ltd., Merseyside, UK). The microdilution broth method was used to determine the minimal inhibitory concentration (MIC) of vancomycin for the isolates that showed resistance phenotype after the disk diffusion method. The results were interpreted according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI) [10 ]. Isolates that showed intermediate levels of susceptibility were classified as non-susceptible. Multidrug-resistance (MDR) was defined as resistance to three or more different classes of antibiotics [11 (link)].
+ Open protocol
+ Expand
6

Antibiotic Susceptibility of Enterococcus spp.

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibiotic susceptibility testing of 175 E. faecalis strains and 67 E. faecium strains was performed using Kirby-Bauer disk diffusion method on Muller-Hinton agar in according to the Clinical and Laboratory Standards Institute (CLSI) guidelines (14 ). Antimicrobial agents used in this study were included: vancomycin (30 μg), teicoplanin (30 μg), tetracycline (30 μg), erythromycin (15 μg), norfloxacin (10 μg), ciprofloxacin (5 μg), nitrofurantoin (300 μg), quinopristin-dalfopristin [synercid (15 μg)] (Mast co., UK), chloramphenicol (30 μg), linezolid (30 μg), gentamicin (10 μg), and ampicillin (10 μg) (HiMedia Mumbai Co., India).
Determination of minimum inhibitory concentration (MIC) of the glycopeptide antibiotics i.e. vancomycin and teicoplanin (Sigma-Aldrich, Poole, Co., UK) for E. faecalis and E. faecium isolates was done using microdilution broth method and Cation Adjustment Muller Hinton Broth (CAMHB) medium according to the CLSI guidelines (14 ). The E. faecalis ATCC 29212 (vancomycin sensitive), E. faecalis ATCC 51299 (vanB positive), E. faecalis E206 (vanA positive) were used as quality control strains for performing antimicrobial tests.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!